Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

News

News
Research and Development Costs for New Drug Development is Increasing, Study Finds
10/16/2023
“The costs required to develop these new products clearly play a role in the incentives to invest in the innovative activities that can generate medical innovation,” wrote the study authors.
“The costs required to develop these new products clearly play a role in the incentives to invest in the innovative activities that can generate medical innovation,” wrote the study authors.
“The costs required to develop...
10/16/2023
Pharmacy Learning Network
News
Upadacitinib Shows Superior Benefits in Treating Active AS
10/16/2023
Results of a recent study show greater clinical and economic benefit regardless of previous treatment.
Results of a recent study show greater clinical and economic benefit regardless of previous treatment.
Results of a recent study show...
10/16/2023
Pharmacy Learning Network

Advertisement

News
The New Vaccines: Americans Better Armed Than Ever Against Winter Colds
10/13/2023
Flu, covid, and respiratory viruses kill thousands of Americans each year, but the latest batch of vaccines could save lives.
Flu, covid, and respiratory viruses kill thousands of Americans each year, but the latest batch of vaccines could save lives.
Flu, covid, and respiratory...
10/13/2023
Pharmacy Learning Network
News
Addressing the Complexities of the Opioid Epidemic Through Economic Evaluation and Policy Design
10/13/2023
New research offers suggestions regarding how economic evaluation can address the challenges of the opioid epidemic in the US, including its magnitude and geographical distribution, intersection with multiple epidemics, rapidly changing...
New research offers suggestions regarding how economic evaluation can address the challenges of the opioid epidemic in the US, including its magnitude and geographical distribution, intersection with multiple epidemics, rapidly changing...
New research offers suggestions...
10/13/2023
Pharmacy Learning Network
News
International Reference Pricing for Prescription Drugs Presents Administrative Complications
10/13/2023
“If the [US] wants to appropriately price drugs and contain their costs and avoid the downsides of international reference pricing, it should also conduct its own assessments to determine how much drugs are worth and negotiate from that...
“If the [US] wants to appropriately price drugs and contain their costs and avoid the downsides of international reference pricing, it should also conduct its own assessments to determine how much drugs are worth and negotiate from that...
“If the [US] wants to...
10/13/2023
Pharmacy Learning Network

Advertisement

News
RSV Incidence Likely Underestimated Due to Low Rates of Testing
10/13/2023
A study revealed significant variation in RSV testing rates across different types of hospitals, with higher testing rates observed in larger, teaching, and urban hospitals compared to their counterparts.
A study revealed significant variation in RSV testing rates across different types of hospitals, with higher testing rates observed in larger, teaching, and urban hospitals compared to their counterparts.
A study revealed significant...
10/13/2023
Pharmacy Learning Network
News
Prospects and Challenges of Adolescent Antiobesity Medication: A Cost-Effectiveness Study
10/13/2023
Adolescent obesity has increased for nearly two decades, affecting more than 1 in 5 adolescents, according to a study published in JAMA Network Open. Researchers recommend intensive health behavior and lifestyle interventions as the...
Adolescent obesity has increased for nearly two decades, affecting more than 1 in 5 adolescents, according to a study published in JAMA Network Open. Researchers recommend intensive health behavior and lifestyle interventions as the...
Adolescent obesity has increased...
10/13/2023
Pharmacy Learning Network
News
Contaminated Eye Drops Recalled
10/12/2023
Concerns of bacterial and fungal contamination have prompted the recall of more than 6000 bottles of Dr Berne’s MSM Drops 15% Solution. The recall was included in the October 11, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Concerns of bacterial and fungal contamination have prompted the recall of more than 6000 bottles of Dr Berne’s MSM Drops 15% Solution. The recall was included in the October 11, 2023, US Food and Drug Administration (FDA) Enforcement Report.
Concerns of bacterial and fungal...
10/12/2023
Pharmacy Learning Network

Advertisement

News
Bladder Drug Recalled
10/11/2023
Zydus Pharmaceuticals (USA) Inc. is recalling 7248 bottles of oxybutynin chloride extended-release tablets after samples failed to meet dissolution specifications during routine testing, according to the October 11, 2023, US Food and Drug...
Zydus Pharmaceuticals (USA) Inc. is recalling 7248 bottles of oxybutynin chloride extended-release tablets after samples failed to meet dissolution specifications during routine testing, according to the October 11, 2023, US Food and Drug...
Zydus Pharmaceuticals (USA) Inc....
10/11/2023
Pharmacy Learning Network
News
Blood Pressure Drug Recalled for Impurities
10/11/2023
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services voluntarily initiated the recall September 1, 2023. The FDA designated the recall Class III on October 5, 2023. Per the Class III designation, use of the affected tablets is not likely to cause harm.
Amerisource Health Services...
10/11/2023
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

Stay Informed & Sign Up Today

Pharmacy Learning Network Newsletter

Advertisement

Video Insights

Videos
David Rubin, MD, on JAK Inhibitors: Small But Mighty
11/22/2023
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his presentation from the Advances in Inflammatory Bowel Disease regional meeting on the latest information on the safety and efficacy of Janus kinase inhibitors for the treatment of inflammatory bowel disease.
Dr Rubin reviews his...
11/22/2023
Pharmacy Learning Network
Videos
Advantages and Drawbacks of Lecanemab in Alzheimer Disease Treatment
11/10/2023
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the FDA-approved lecanemab for the treatment of AD.
Dr Shulz discusses the...
11/10/2023
Pharmacy Learning Network
Videos
Immunosuppressants or Immunomodulators? Biologic Agents for Psoriasis
10/27/2023
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr Ronald Vender goes over the highly effective targeted biologic therapies used to treat psoriasis.
In this exclusive interview, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Application of Dupilumab to Pediatric Patients With Atopic Dermatitis
10/27/2023
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr Abigail Cline discusses current literature to assess reported efficacies, side effects, and risks of using dupilumab to treat atopic dermatitis in pediatric patients.
In this feature video, Dr...
10/27/2023
Pharmacy Learning Network
Videos
Patient Considerations When Prescribing Lecanemab for Alzheimer Disease
10/06/2023
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the newly FDA-approved lecanemab for the treatment of AD.
Dr Paul Schulz discusses the...
10/06/2023
Pharmacy Learning Network
Headshots of Chris Fausel, PharmD, MHA, BCOP; Erin Hamai Tom, PharmD, APh, MBA, BCACP; and Ryan Nix, PharmD, MMHC
Videos
Specialty Pharmacy Next: Focus on Distribution Processes, Data Utilization, New Drugs, and More
07/18/2023
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of Specialty Pharmacy Next gather to discuss pertinent topics on the agenda such as white and brown bagging practices and data usage for program growth, as well as who may benefit most from attending the meeting.
In this roundtable, cochairs of...
07/18/2023
Pharmacy Learning Network
Videos
Leaders in Pharmacy Come Together to Discuss and Debate Oncology-Related Developments
06/28/2021
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams, PharmD, Kirollos Hanna, PharmD, and Lisa Holle, PharmD, cochairs of Great Debates and Updates Oncology Pharmacy, come together to discuss this new CPE event aimed at educating pharmacists interested in...
Chris Fausel, PharmD, Val Adams,...
06/28/2021
Pharmacy Learning Network
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
Videos
Expanded FDA Approval Improves Care Access, Rates of Flu Cases
04/19/2021
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief medical officer, and David Ross, vice president, commercial operations for North America, both at Seqirus, discuss the recent FDA approval for Flucelvax Quadrivalent, explain what the expanded indication means...
Gregg Sylvester, MD, MPH, chief...
04/19/2021
Pharmacy Learning Network
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
Videos
Identifying Drug Diversion Differences in Retail Pharmacies Compared With Health Systems
12/28/2020
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO, Invistics, identifies drug diversion differences in a hospital or health system versus a retail pharmacy, and explains what retail pharmacies can do to better detect and address drug diversion.
Tom Knight, founder and CEO,...
12/28/2020
Pharmacy Learning Network
Identifying Risks of Human Error, Workarounds in Pharmacy
Videos
Identifying Risks of Human Error, Workarounds in Pharmacy
12/22/2020
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP, FASCP, director of Error Reporting Programs, Institute for Safe Medication Practices, discusses how human error, various at-risk behaviors, as well as workarounds taken by staff members all impact outcomes and...
Matthew Grissinger, RPh, FISMP,...
12/22/2020
Pharmacy Learning Network

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use